Synthetic organic polysulfanes as H2S donors and anticancer agents.

Abstract

Organic polysulfanes are one of the major classes of organic sulfur compounds (OSCs) with pharmaceutical and medicinal implications for various diseases. The biological impacts of organic polysulfanes, particularly their role as hydrogen sulfide (H₂S) donors, have gained significant attention in scientific research over the past two decades. Notably, H₂S has been recognized for its multiple bio-potentials, including its ability to inhibit the proliferation of cancer cells. The feasible reaction of the polysulfane unit of organopolysulfanes with nucleophilic biothiols leads to the sustained release of H₂S. The released H₂S from various organopolysulfanes opens up new therapeutic windows for utilizing them as potent anticancer and chemopreventive agents for treating different organ-specific cancers. Despite these promising therapeutic implications, a comprehensive understanding of the synthesis and capability of various synthetic organopolysulfanes to release H₂S, along with the implications of the released H₂S for their pharmacological potentials, remain elusive. Therefore, this review aims to fill the gap by exploring the synthesis and H₂S donating capacities of various synthetic organopolysulfanes and their pharmacological benefits for cancer treatment. The insights provided here will help correlate synthetic organopolysulfanes as H₂S donors with their therapeutic potentials, offering a clearer perspective on their roles in drug development.